World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Park KH, Yoo JJ, Kim SG, Kim YS. Fatal intratumoral hemorrhage in a patient with hepatocellular carcinoma following successful treatment with atezolizumab/bevacizumab: A case report. World J Clin Cases 2024; 12(22): 5177-5183 [PMID: 39109046 DOI: 10.12998/wjcc.v12.i22.5177]
URL:	https://www.wjgnet.com/2307-8960/full/v12/i22/5177.htm

(116) (114) (0) (0) (0) (5) (3627) (6)

Number	Citing Articles
1	Kazuhiro Tada, Shohei Yoshiya, Takaaki Mori, Ryoichi Narita, Kentaro Iwaki, Sota Nakamura, Yasunari Yamada, Hajime Takaki, Yo-ichi Yamashita, Kengo Fukuzawa. Tumor Rupture in a Patient with Recurrent Hepatocellular Carcinoma Following Atezolizumab plus Bevacizumab: A Case Report. Surgical Case Reports 2025; 11(1) doi: 10.70352/scrj.cr.25-0331
2	Takashi Takeuchi, Hajime Yokota, Jun Koizumi, Akiyo Takada, Maaya Miyakoshi, Sadahisa Ogasawara, Naoya Kanogawa, Masanori Inoue, Keisuke Koroki, Sae Yumita, Takuro Horikoshi, Katsuhiro Nasu, Takashi Uno. Intratumoral Hemorrhage Induced by Atezolizumab plus Bevacizumab Combination Therapy in Patients with Hepatocellular Carcinoma. Oncology 2026; doi: 10.1159/000551878
3	Kazuya Murakawa, Fujimasa Tada, Atsushi Hiraoka, Hideko Ohama, Yuka Kimura, Ayaka Nakamura, Kana Matsuoka, Takuya Matsuda, Kanako Kato, Kei Onishi, Hirofumi Izumoto, Shogo Kitahata, Kozue Kanemitsu-Okada, Tomoe Kawamura, Taira Kuroda, Hideki Miyata, Eiji Tsubouchi, Hiroshi Sakaeda, Yoshiko Nakamura, Teruki Miyake, Masashi Hirooka, Tomoyuki Ninomiya, Yoichi Hiasa. Two cases of unresectable hepatocellular carcinoma with intratumoral aneurysm formation during atezolizumab/bevacizumab therapy. Kanzo 2025; 66(9) doi: 10.2957/kanzo.66.397
4	Multiple drugs. Reactions Weekly 2024; 2019(1) doi: 10.1007/s40278-024-64250-1
5	Zhihong Chen, Junwei Zhang, Lei Zhang, Yaoge Liu, Ting Zhang, Xinting Sang, Yiyao Xu, Xin Lu. Evaluation of immune checkpoint inhibitor-associated hepatotoxic adverse events: A pharmacovigilance analysis based on the FAERS database. International Journal of Immunopathology and Pharmacology 2025; 39 doi: 10.1177/03946320251343943
6	Mohamed El-Kassas, Ahmed Tawheed, Mina Tharwat. Atezolizumab and bevacizumab combination in advanced hepatocellular carcinoma patients: The imperative for safety assessment studies. World Journal of Clinical Cases 2025; 13(9): 99043 doi: 10.12998/wjcc.v13.i9.99043 Abstract(591) \| Core Tip(623) \| Full Article(HTML)(1792) \| Full Article (PDF)-341K(142) \| Full Article with Cover (PDF)-619K(182) \| Full Article (XML)-47K(109) \| Audio-152K(13) \| Peer-Review Report-219K(101) \| Answering Reviewers-57K(112) \| Times Cited (0) \| Total Visits (2225) \| Open

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.